One drug class that has garnered interest in the management of neuro-ophthalmic conditions is glucagon-like peptide 1 receptor agonists (GLP-1RAs)
One of the first signs of this was the weight loss reported by patients using GLP-1 drugs for their diabetes
Whether glucagon counter-regulation to hypoglycemia is affected during DPP-4 inhibition in type 2 diabetes has been studied in drug-nave subjects (138), in subjects when a DPP-4 inhibition was added on to insulin therapy (139), and in elderly subjects with metformin-treated type 2 diabetes (140)
This scientific term covers the bad things that happen, such as the death of a loved one, divorce, major changes in relationships, job loss, financial problems, workplace stress, childhood abuse, chronic illness, injury, moving, and transitioning into adulthood.[ref] Reduced sleep quality and quantity have strong links to major depressive disorder
Its his daily lifestyle